Survival Study of Docetaxel and Carboplatin as Neo-Adjuvant Vs Adjuvant Chemotherapy in Early Stage NSLC

NCT00321334 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
410
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Chinese Society of Lung Cancer